30
Views
13
CrossRef citations to date
0
Altmetric
Review Article

Long-term Health Risk of Primary Hyperparathyroidism: The Effect of Surgery

&
Pages 95-100 | Published online: 08 Jul 2009

References

  • Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1976; 200: 131–7
  • Heath H, III, Hodgson S F, Kennedy M A. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302: 189–93
  • Palmér M, Jakobsson S, Åkerström G, Ljunghall S. Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988; 18: 39–46
  • Ljunghall S, Hellman P, Rastad J, Akerstrom G. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg 1991; 15: 681–7
  • Ronni-Sivula H. Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985; 74: 13–8
  • Palmér M, Adami H-O, Bergström R, Åkerström G, Ljunghall S. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987; 102: 1–7
  • Palmér M, Adami H-O, Bergstrom R, Jakobsson S, Åkerström G, Ljunghall S. Survival and renal function in untreated hypercalcemia. Population-based cohort study with 14 years of follow-up. Lancet 1987; i: 59–62
  • Hedbäck G, Tisell L-E, Bengtsson B-Å, Hedman I, Odén A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 1990; 14: 829–36
  • Marx S J. Genetic defects in primary hyperparathyroidism. N Engl J Med 1988; 318: 699–701
  • Posen S. Asymptomatic primary hyperparathyroidism: the case for conservative management. Aust N Z J Med 1992; 22: 161–3
  • Silverberg S J, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989; 4: 283–91
  • Rao D S, Wilson R J, Kleerekoper M, Parfitt A M. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 1988; 67: 1294–8
  • Wilson R J, Rao D S, Ellis B, Kleerekoper M, Parfitt A M. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988; 109: 959–62
  • Heath D A. Primary hyperparathyroidism. Clinical presentation and factors influencing clinical management. Endocrinol Metab Clin North Am 1989; 18: 631–46
  • Ronni-Sivula H, Sivula A. Long-term effect of surgical treatment on the symptoms of primary hyperparathyroidism. Ann Clin Res 1985; 17: 141–7
  • Lafferty F W, Hubay C A. Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment. Arch Intern Med 1989; 149: 789–96
  • Prager R, Schernthaner G, Niederle B, Roka R. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif Tissue Int 1990; 46: 1–4
  • Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95: 197–202
  • Patten B M, Bilezikian J P, Mallette L E, Prince A, Engel W K, Aurbach G D. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med 1974; 80: 182–93
  • Joborn C, Joborn H, Rastad J, Åkerström G, Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 1988; 75: 77–80
  • Joborn C, Hetta J, Lind L, Rastad J, Åkerström G, Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989; 105: 72–8
  • Clark O H, Wilkes W, Siperstein A E, Duh Q Y. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiences in our knowledge. J Bone Miner Res 1991; 6: S135–42, Suppl 2
  • Heath D A, Heath E M. Conservative management of primary hyperparathyroidism. J Bone Miner Res 1991; 6: S117–20, Suppl 2
  • Christensson T, Hellström K, Wengle B. Clinical and laboratory findings in subjects with hypercalcemia. A study including cases with primary hyperparathyroidism detected in a health screening. Acta Med Scand 1976; 200: 355–60
  • Harrison B J, Wheeler M H. Asymptomatic primary hyperparathyroidism. World J Surg 1991; 15: 724–9
  • Brown E M, Pollak M, Seidman C E, et al. Calciumion-sensing cell-surface receptors. N Engl J Med 1995; 333: 234–9
  • Russell C F, Edis A J. Surgery for primary hyperparathyroidism. Experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg 1982; 69: 244–7
  • Kjellman M, Sandelin K, Farnebo L-O. Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation. Arch Surg 1994; 129: 237–40
  • Kairaluoma M V, Makarainen H, Kellosalo J, Haukipuro K, Pirttiaho H, Kairaluoma Ml. Preoperative ultrasound in patients undergoing initial neck exploration for primary hyperparathyroidism. Ann Chir Gynaecol 1993; 82: 171–6
  • Sivula A, Ronni-Sivula H. Observations on 334 patients operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985; 74: 66–73
  • Alhava E M, Karjalainen P, Pääkkönen P. Bone mineral density and surgical treatment of primary hyperparathyroidism. Acta Chir Scand 1988; 154: 345–7
  • Mautalen C, Reyes H R, Ghiringhelli G, Fromm G. Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy. Acta Endocrinol 1986; 111: 494–7
  • Wells A, Jr. Surgical therapy of patients with primary hyperparathyroidism: long-term benefits. J Bone Miner Res 1991; 6: S143–9, Suppl 2
  • Heath D A, Wright A D, Barnes A D, Oates G D, Dorricott N J. Surgical treatment of primary hyperparathyroidism in the elderly. BMJ 1980; 280: 1406–8
  • Joborn C, Hetta J, Rastad J, Agren H, Akerstrom G, Ljunghall S. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry 1988; 23: 149–58
  • Sivula A, Ronni-Sivula H. Natural history of treated primary hyperparathyroidism. Surg Clin North Am 1987; 67: 329–41
  • Hedbäck G, Odén A, Tisell L-E. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991; 15: 399–407
  • Hedbäck G, Odén A. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur J Clin Invest 1995; 25: 48–52
  • Hedbäck G, Odén A, Tisell L-E. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 1995; 117: 134–9
  • Bilezikian J P. Management of hypercalcemia. J Clin Endocrinol Metab 1993; 77: 1445–9
  • NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism. Consensus development conference statement. Ann Intern Med 1991; 114: 593–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.